NBIX — Neurocrine Biosciences, Inc. stock price, charts and financials

QT58Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
146.23
-5.60-3.69%
OverviewShort InterestFilings
NBIXQT58Neurocrine Biosciences, Inc.·NASDAQ
146.23-3.69%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 10, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 05, 20264Statement of changes in beneficial ownership
Jul 31, 2026S-8Registration of employee benefit securities
Jul 31, 202610-QQuarterly report
Jul 31, 20268-K/ACurrent report (amended)
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 20268-KCurrent report
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 13, 20264Statement of changes in beneficial ownership
Jul 13, 20264Statement of changes in beneficial ownership
Jul 09, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
#1 / 25 of 515
Page
▼
/ 21